EPN

EPSILON FPO [EPN]
Epsilon Healthcare Limited, together with its subsidiaries, engages in the healthcare business in Australia. The company operates in three segments, Contract Development and Manufacturing Activities, Telehealth Medical Practice Services, and Pharmacy Services. It is involved in the healthcare and clinics operation; pharmaceutical contract development and manufacturing; development and manufacturing of active pharmaceutical ingredients and finished formulation; and provision of pharmacy services and patient care. The company was formerly known as THC Global Group Limited and changed its name to Epsilon Healthcare Limited in February 2021. Epsilon Healthcare Limited was incorporated in 2016 and is based in Southport, Australia.
Healthcare · ASX Small Cap
$0.0220 +0.0%

Updated 22 Jul 2026 · Signals refresh every scan

Get alerts when EPN triggers a new signal
Free watchlist with daily scans for 2,200+ ASX stocks
Track EPN — Free

Active Signals

Bullish Signals

  • Stochastic is deep in oversold territory — bounce conditions forming
  • Sitting near support — this level has held before and could attract buyers again
  • Volume-price trend suggests distribution — sellers may be sneaking out while price holds
  • Volatility is expanding fast — choppy price action, so buckle up
  • Critical cash runway (0.3 quarters)
  • Low P/S ratio (0.9x)
  • Strong revenue growth (+119%)
  • Near 52-week low (14% of range)
  • Micro-cap ($5-20M) - high risk
  • New substantial holder(s) (1)
  • Sentiment is mixed — no strong consensus either way
  • Revenue growing at +119% — the top line is moving in the right direction
  • The bigger volume days are the up days — volume-weighted momentum is positive (1.18%/day)
  • Altman Z-Score distress zone (0.13 < 1.81, low-confidence approx)
  • Low-priced stock risk ($0.022)
  • Beneish M-Score 0.33 > -1.78: likely earnings manipulation
  • RBA hiking (-3pts)

Risk Signals

  • MACD crossed bearish — momentum is fading
  • Trading below both moving averages — the trend is working against this one
  • Below the 200-day average — the long-term trend is still working against it
  • Piotroski F-Score weak (2/9, low-confidence approx)
  • Negative profit margins (-14%)
  • Not enough chatter to gauge sentiment — defaulting to neutral
Ask Scout AI about EPN
"What's driving EPN today?" "How does EPN compare to peers?" "Key risks for EPN?"
3 free messages/day · Unlimited with Pro

Recent Catalysts

NONE Change in substantial holding
NONE Change of Director's Interest Notice - Zoe Hutchings
NONE Company Debt Arrangements - update
HIGH Becoming a substantial holder
Announcement tone +3pts

Recent ASX Announcements

2026-07-08 Change in substantial holding
2026-07-08 Becoming a substantial holder
2026-07-06 Change of Director's Interest Notice - Zoe Hutchings
2026-06-30 Company Debt Arrangements - update
2026-06-26 Closure of small holding share sale facility

Key Metrics

$8.6M
Market Cap
58K
Avg Volume
1.0x
Vol Ratio
$0.02 — $0.04
52-Week Range
N/A
Short Interest
N/A
Cash Runway
N/A
ROE
-13.6%
Profit Margin

CANSLIM Analysis

FactorRatingDetail
CCurrent EPSfailEPS Growth: 0%
AAnnual EarningsfailCAGR: 0%
NNew Highs / Catalystsneutral
SSupply & DemandneutralFloat: 63%
LLeader vs LaggardpassRS: 5
IInstitutional Sponsorshipinsufficient_dataInst: 0%
MMarket DirectionneutralNeutral

Sector: Healthcare

101 tickers in this sector

View all Healthcare signals →Browse all ASX tickers A–Z →
Related Tickers
IDT +28.1%ADR +27.3%LDX +23.8%EYE +17.4%ECS -16.7%
Compare:EPN vs IDTEPN vs ADREPN vs LDX
Scout Pro — Deeper Analysis for EPN
Try Pro free for 30 days
Share this analysis

Track EPN and 2,200+ ASX stocks

Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and exit management for every ASX small cap.

Open Dashboard — Free Free Screener
No credit card required